Table 1.
PTN subject characteristics
Subject | Age (years) | Gender | Pain duration (years) | Pain intensity (VAS) | Location | Analgesic medication | BDI | PCS |
---|---|---|---|---|---|---|---|---|
1 | 51 | Male | 3.5 | 2.1 | Right | None | 6 | 10 |
2 | 47 | Female | 5 | 1.1 | Left | None | 24 | 47 |
3 | 52 | Female | 1.5 | 6.9 | Bilateral | Oxycodone hydrochloride, paracetamol | 18 | 29 |
4 | 55 | Female | 2 | 5.2 | Left | Docusate sodium; sennosides, amitriptyline, gabapentin, oxycodone, paracetamol | 21 | 25 |
5 | 42 | Female | 11 | 4.8 | Right | Carbamazepine | 34 | 36 |
6 | 54 | Female | 6.5 | 1.6 | Right | Amitriptyline | 9 | 20 |
7 | 44 | Female | 2 | 6.4 | Left | None | 11 | 15 |
8 | 41 | Female | 3.5 | 4.0 | Left | None | 6 | 11 |
9 | 67 | Female | 14 | 8.4 | Left | None | 4 | 29 |
10 | 43 | Male | 16 | 5.8 | Left | Desvenlafaxine | 5 | 9 |
11 | 44 | Female | 1.5 | 1.2 | Right | Ibuprofen, codeine phosphate, paracetamol | 19 | 25 |
12 | 65 | Female | 7 | 2.5 | Left | Amitriptyline, paracetamol | 6 | 11 |
13 | 50 | Female | 7 | 0.5 | Right | None | 6 | 2 |
14 | 67 | Female | 20 | 4.2 | Right | Thyroxine sodium, rosuvastatin, venlafaxine, pregabalin, phenylethylamine, ergotamine | 32 | 18 |
15 | 67 | Female | 3 | 8.4 | Left | None | 6 | 5 |
16 | 43 | Male | 9 | 5.8 | Left | Desvenlafaxine | 30 | 29 |
17 | 44 | Female | 7.5 | 1.2 | Right | None | 5 | 35 |